nContact, headquartered in Morrisville, NC, was founded to develop and investigate medical devices for the minimally invasive treatment of heart arrhythmias.
Our enabling product, the Numeris® Coagulation System with VisiTrax®, is indicated for the coagulation of cardiac tissue in the USA.
We are currently enrolling patients in a series of clinical trials to evaluate the use of this system for the treatment of atrial fibrillation (AF) in concomitant procedures as well as in convergent procedures, which combine the best techniques of Cardiovascular Surgeons and Electrophysiologists to potentially provide a truly minimally invasive treatment solution for all AF patients in a single procedure.
For information about our international operations, please visit http://www.ncontactsurgical.eu/
Tethered Coagulation System
The Numeris® Coagulation System with VisiTrax® integrates suction, perfusion, and RF energy to create visible, non-conductive, bi-atrial, epicardial lesions on a beating heart. The tethered device is used in open chest concomitant procedures.
.jpg)
Guided Coagulation System
The guided device is used in closed chest procedures and allows the coil end to be maneuvered along a guidewire, through the paracardioscopic cannula, to endoscopically create bi-atrial lesions.
Open & Closed Chest Clinical Trials for the Treatment of AF
nContact has initiated clinical trials for the treatment of longstanding persistent AF in open-chest procedures and symptomatic paroxysmal AF in closed-chest convergent procedures.
